Faculty profile

Sonia Cellot

ResearcherUniversité de Montréal

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Montréal directory, so their courses may be missing. Find their university profile.

Sonia Cellot

Researcher

Health Sciences

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
8 publications in the last five years, latest in 2026.
Principal investigator on 1 research grant (1 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

117

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Bcl-Xl Bcl2 Bh3 Mimetics Cbfa2t3-Glis2 Fusion Cord Blood Stem/Progenitor Cells Drug Screen Mitochondrial Apoptosis Nup98 Fusions

Latest papers

Cell-Free DNA Uncovered Tumor Heterogeneity and Informed Targeted Therapy in a Pediatric Rhabdomyosarcoma.
JCO precision oncology · 2026
BH3 mimetic therapies for CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia.
Trends in molecular medicine · 2026
Defining the window of opportunity for post-transplant ThINKK therapy and TRAIL as a biomarker of NK cell response.
Cytotherapy · 2026

All 26 publications

Latest funding

Targeting leukemia fusion antigens; from peptidomics to T-cell therapy
CIHR · 2026 · Co-investigator
$1,032,750
Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers
CIHR · 2023 · Co-investigator
$100,000
Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers
CIHR · 2022 · Co-investigator
$100,000

All 5 grants and awards

26 publications.

Cell-Free DNA Uncovered Tumor Heterogeneity and Informed Targeted Therapy in a Pediatric Rhabdomyosarcoma.

Faucher J, Richer C, Langlois S, Rouette A, Bianco S, Sontag T, Lepage MÈ, Da Silva E, Cellot S, Tran TH, Parbhoo K, Cottrell CE, Sinnett D, Michon B, Lavallée VP, Santiago R

JCO precision oncology2026

DOI: 10.1200/po-25-00948 PMID: 42114036

BH3 mimetic therapies for CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia.

Capdevielle C, St-Amand S, Neault M, Gruber TA, Cellot S, Mallette FA

Trends in molecular medicine2026

DOI: 10.1016/j.molmed.2025.09.006 PMID: 41058336

Defining the window of opportunity for post-transplant ThINKK therapy and TRAIL as a biomarker of NK cell response.

Ollame-Omvane É, Khemis LB, Cordeiro P, Galopin M, Frizot M, Leveille K, Usmani N, Teira P, Cellot S, Bittencourt H, Herblot S, Duval M

Cytotherapy2026

DOI: 10.1016/j.jcyt.2026.102910 PMID: 42462594

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Safa-Tahar-Henni S, Páez Martinez K, Gress V, Esparza N, Roques É, Bonnet-Magnaval F, Bilodeau M, Gagné V, Bresson E, Cardin S, El-Hachem N, Iasenza I, Alzial G, Boivin I, Nakamichi N, Soufflet AC, Mirela Pascariu C, Duchaine J, Mathien S, Bonneil É, Eppert K, Marinier A, Sauvageau G, Deblois G, Thibault P, Hébert J, Eaves CJ, Cellot S, Barabé F, Wilhelm BT

Leukemia2025

DOI: 10.1038/s41375-024-02400-w PMID: 39472547

Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis.

Beaufils C, Proulx C, Blincoe A, Teira P, Bittencourt H, Cellot S, Duval M, Morin MP, De Bruycker JJ, Couture J, Samaan K, Decaluwe H, Kleiber N, El-Jalbout R, Touzot F, Haddad E, Barsalou J

Frontiers in medicine2023

DOI: 10.3389/fmed.2023.1275927 PMID: 37908851

Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes

Hebert R, Cullinan N, Armstrong L, Blood KA, Brossard J, Brunga L, Cacciotti C, Caswell K, Cellot S, Coltin H

Journal of Medical Genetics20235 citations

DOI: 10.1136/jmg-2023-109376

Durable Response to Trametinib in an Infant With ERC1-BRAF Infantile Fibrosarcoma-Like Tumor: A Case Report and Literature Review of BRAF-Altered Infantile Fibrosarcoma-Like Tumors.

Gourmel A, Rouette A, Benlimame N, El-Jalbout R, Dubé M, Théorêt Y, Piché N, Labonté S, Sinnett D, Cellot S, Dal-Soglio D, Larouche V, Tran TH

JCO precision oncology2022

DOI: 10.1200/po.22.00200 PMID: 36103644

Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C

Tibout P, Ledjiar O, Athale U, Rayar M, Kulkarni K, Truong T, Cellot S, Bittencourt H, Pelland-Marcotte M-C, Tran TH

Leukemia and Lymphoma20222 citations

DOI: 10.1080/10428194.2022.2118536

Intrabone infusion for allogeneic umbilical cord blood transplantation in children.

Vairy S, Louis I, Vachon MF, Richer J, Teira P, Cellot S, Villeneuve E, Haddad E, Duval M, Bittencourt H

Bone marrow transplantation2021

DOI: 10.1038/s41409-021-01275-0 PMID: 33824433

Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes

Goudie C, Witkowski L, Cullinan N, Reichman L, Schiller I, Tachdjian M, Armstrong L, Blood KA, Brossard J, Brunga L

JAMA Oncology202159 citations

DOI: 10.1001/jamaoncol.2021.4536

Targeting leukemia fusion antigens; from peptidomics to T-cell therapy

Co-investigatorCIHR2026Project Grant

Principal investigators: Delisle, Jean-Sébastien

Keywords: Fusion Protein; Gene Engineering; Immunotherapy; Leukemia; Neo-Antigens; Pediatric Cancers; T-Cell Immunotherapy; T-Cell Receptors

$1,032,750

Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers

Co-investigatorCIHR2023Project Grant - Priority Announcement: Pediatric Cancer Research

Principal investigators: Duval, Michel

Keywords: Adoptive Immunotherapy; Cell Therapy Manufacturing; Childhood Cancer; First-In-Human Clinical Trial; Hematopoietic Stem Cell Transplantation; Nk Cell-Based Immunotherapy

$100,000

Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers

Co-investigatorCIHR2022Project Grant - Priority Announcement: Pediatric Cancer Research

Principal investigators: Duval, Michel

Keywords: Adoptive Immunotherapy; Cell Therapy Manufacturing; Childhood Cancer; First-In-Human Clinical Trial; Hematopoietic Stem Cell Transplantation; Nk Cell-Based Immunotherapy

$100,000

Canadian Pediatric Cancer Consortium

Co-investigatorCIHR2022Team Grant: Pediatric Cancer Consortium

Principal investigators: David Malkin, James Whitlock; Co-Dyre, Adrienne; McIntosh, Keith A; Denburg, Avram E; Deyell, Rebecca J; Duval, Michel; Jabado, Nada; Marjerrison, Stacey L; Rayar, Meera; Tsimicalis, Argerie

Keywords: Cancer -Omics; Cancer Modeling; Clinical Trials; Community Engagement; Implementation Science; Innovative Therapies; Knowledge Mobilization; Pan-Canadian Consortium; Pediatric Cancer; Training And Mentorship

$23,000,000

Exploiting induction of mitochondrial apoptosis as a therapeutic vulnerability in high fatality pediatric leukemia

Nominated PICIHR2021Project Grant

Principal investigators: Cellot, Sonia

Keywords: Bcl-Xl; Bcl2; Bh3 Mimetics; Cbfa2t3-Glis2 Fusion; Cord Blood Stem/Progenitor Cells; Drug Screen; Mitochondrial Apoptosis; Nup98 Fusions; Patient-Derived-Xenografts; Pediatric Leukemia

$944,776

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Sonia Cellot

Research

Latest papers

Latest funding

Cell-Free DNA Uncovered Tumor Heterogeneity and Informed Targeted Therapy in a Pediatric Rhabdomyosarcoma.

BH3 mimetic therapies for CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia.

Defining the window of opportunity for post-transplant ThINKK therapy and TRAIL as a biomarker of NK cell response.

Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell lines.

Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis.

Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes

Durable Response to Trametinib in an Infant With ERC1-BRAF Infantile Fibrosarcoma-Like Tumor: A Case Report and Literature Review of BRAF-Altered Infantile Fibrosarcoma-Like Tumors.

Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C

Intrabone infusion for allogeneic umbilical cord blood transplantation in children.

Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes

Targeting leukemia fusion antigens; from peptidomics to T-cell therapy

Phase I first-in-human trial for ThINKK adoptive immunotherapy in children with high-risk cancers

Phase I first-in-human trial of ThINKK adoptive immunotherapy in children with high-risk cancers

Canadian Pediatric Cancer Consortium

Exploiting induction of mitochondrial apoptosis as a therapeutic vulnerability in high fatality pediatric leukemia

Frequent collaborators

Michel Duval

Nada Jabado

Guy Sauvageau

Victor Lewis

Daniel Sinnett

Lillian Sung

Joseph Beyene

Paul Gibson

Martin Sauvageau

Catherine Goudie

David Malkin

Adam Fleming

Elie Haddad

Fabien Touzot

Marie-Claude Pelland-Marcotte

Donna Johnston

Gino Somers

Vijay Ramaswamy

Adam Shlien

Sebastien Perreault

Uma Athale

Uri Tabori

Kolja Eppert

Nandini Dendukuri

Sylvain Meloche